InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Kristin Abate, Chief Accounting Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 9 open-market SEC Form 4 transactions: 0 purchases worth $0 and 9 sales worth $15K, reported from Mar 4, 25 to May 14, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| May 14, 26 | KPTIKaryopharm Therapeutics Inc. | SELL | 53 | $9.50 | $504 |
| Mar 2, 26 | KPTIKaryopharm Therapeutics Inc. | SELL | 559 | $9.41 | $5K |
| Jan 28, 26 | KPTIKaryopharm Therapeutics Inc. | SELL | 50 | $7.03 | $352 |
| Jan 21, 26 | KPTIKaryopharm Therapeutics Inc. | SELL | 265 | $5.96 | $2K |
| Oct 1, 25 | KPTIKaryopharm Therapeutics Inc. | SELL | 362 | $6.30 | $2K |
| Sep 15, 25 | KPTIKaryopharm Therapeutics Inc. | SELL | 23 | $6.43 | $148 |
| Sep 3, 25 | KPTIKaryopharm Therapeutics Inc. | SELL | 12 | $6.78 | $81 |
| Jul 22, 25 | KPTIKaryopharm Therapeutics Inc. | SELL | 238 | $4.00 | $952 |
| Mar 4, 25 | KPTIKaryopharm Therapeutics Inc. | SELL | 571 | $6.29 | $4K |